Characteristic | Number responding (%) | Odds ratio for response4 (95% confidence interval) | Final model: Adjusted odds ratio5 (95% CI) |
---|---|---|---|
All centers | 714 (67.5) | ||
Center Variables | |||
Lyon (reference) | 134 (72.8) | reference | |
Paris | 91 (50.0) | 0.37 (0.24, 0.57) | |
Grenoble | 8 (23.5) | 0.11 (0.05, 0.27) | |
Marseille | 69 (75.8) | 1.16 (0.65, 2.06) | |
Nice | 33 (75.0) | 1.12 (0.53, 2.38) | |
Toulouse | 44 (60.3) | 0.56 (0.31, 0.99) | |
Copenhagen | 9 (64.3) | 0.67 (0.21, 2.1) | |
Vienna | 134 (71.7) | 0.97 (0.61, 1.54) | |
Stockholm | 8 (50.0) | 0.37 (0.13, 1.05) | |
Naples | 50 (94.3) | 6.22 (1.85, 20.84) | |
Poznan | 134 (74.4) | 1.09 (0.68, 1.73) | |
Total score for organisational attributes 3 | 9 (6,10) | 1.36 (1.27, 1.45) | 1.15 (1.09, 1.23) |
Infection status 1 | |||
CT+ | 178 (80%) | 2.95 (2.01, 4.31) | 4.96 (3.58, 6.88) |
CT- | 527 (64%) | ||
Maternal age 1,2,3 (mean years, 95% CI) | 582 (67%) 28.4 (27.6, 29.2) | 1.03 (0.99, 1.07) | 1.02 (0.99, 1.05) |
Parity 1,2,3 (mean, 95% CI) | 503 (67%) 0.9 (0.8, 1.0) | 1.05 (0.90, 1.23) | |
Gestational age at birth 1,2,3 (mean weeks, 95% CI) | 530 (68%) 39.0 (38.8, 39.1) | 1.00 (0.92, 1.09) | |
Child's gender 1,2 | |||
Male | 379 (68%) | Reference | |
Female | 316 (68%) | 0.94 (0.71, 1.25) | |
Prenatal treatment 1,2 | |||
Any prescribed | 532 (67%) | 1.85 (0.98, 3.49) | |
None | 62 (66%) | ||
Neurological abnormality and/or intracranial lesions 1,2 | |||
Yes | 25 (83.3) | 2.69 (0.56, 13.00) | |
No | 569 (66.3) |